|
Sep 26
|
Buy These 5 Big Drug Stocks to Boost Your Portfolio's Health
|
|
Sep 26
|
AstraZeneca in AI collaboration with Immunai to inform cancer drug trials
|
|
Sep 26
|
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
|
|
Sep 26
|
TAGRISSO® (osimertinib) approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer
|
|
Sep 25
|
Has Arbutus Biopharma (ABUS) Outpaced Other Medical Stocks This Year?
|
|
Sep 25
|
AstraZeneca PLC (AZN): A Risky Bet on Emerging Cancer Treatments
|
|
Jul 29
|
Fixed-duration CALQUENCE® (acalabrutinib) plus venetoclax, with or without obinutuzumab, significantly improved progression-free survival in 1st-line chronic lymphocytic leukemia in AMPLIFY Phase III trial
|
|
Jul 28
|
AstraZeneca (LON:AZN) Has Announced A Dividend Of $0.776
|
|
Jul 27
|
AstraZeneca Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Jul 26
|
FDA committee proposes overhaul of perioperative lung cancer trials
|
|
Jul 26
|
3 Surprisingly Underrated Stocks to Buy Right Now
|
|
Jul 26
|
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
|
|
Jul 26
|
Top 3 UK Stocks Estimated To Be Undervalued In July 2024
|
|
Jul 26
|
AstraZeneca CEO talks dual supply chain strategy
|
|
Jul 25
|
AstraZeneca Says It Has A 'Powerful' — And Differentiated — Approach To Obesity Treatment
|
|
Jul 25
|
US economy keeps growing, Astrazeneca CEO describes challenges: Catalysts
|
|
Jul 25
|
AstraZeneca CEO: We're building '2 supply chains' to avoid impact of US-China tensions
|
|
Jul 25
|
Top Midday Stories: US Advance Q2 GDP Rises; Initial Jobless Claims Drop; Ford Earnings Fall; TotalEnergies' Lower Results; AbbVie Raises Guidance; IBM, ServiceNow Report Higher Results
|
|
Jul 25
|
Why AstraZeneca Stock Is Sliding Today
|
|
Jul 25
|
AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript
|